Falsified Medicines Directive in a Secondary Care Environment-Impact on Supply Chain

被引:2
|
作者
Merks, Piotr [1 ]
Religioni, Urszula [2 ]
de Castro, Nuno Pinto [3 ]
Augustynowicz, Anna [2 ,4 ]
Plagens-Rotman, Katarzyna [5 ]
Brindley, David [6 ]
Kowalczuk, Anna [7 ]
Kazmierczak, Justyna [8 ]
Neumann-Podczaska, Agnieszka [9 ]
Blicharska, Eliza [10 ]
Sola, Katarina Fehir [11 ]
Hug, Martin J. [12 ]
Gajewski, Klaudiusz [13 ]
Piatkiewicz, Pawel [14 ]
机构
[1] Cardinal Stefan Wyszynski Univ, Coll Med, Fac Med, PL-01938 Warsaw, Poland
[2] Ctr Postgrad Med Educ Warsaw, Sch Publ Hlth, PL-01826 Warsaw, Poland
[3] Open Univ, Business Sch, Walton Hall,Kents Hill, Milton Keynes MK7 6AA, Bucks, England
[4] Med Univ Warsaw, Dept Econ Hlth & Med Law, PL-02091 Warsaw, Poland
[5] Hipolit Cegielski State Univ Appl Sci, Inst Hlth Sci, PL-62200 Gniezno, Poland
[6] Univ Oxford, UCL Ctr Adv Sustainable Med Innovat CASMI, Oxford OX2 0JB, England
[7] Natl Inst Med, PL-00725 Warsaw, Poland
[8] Zdrowit Sp Zoo, Pharm Chain, PL-41940 Piekary Sluskie, Poland
[9] Poznan Univ Med Sci, Chair & Dept Palliat Med, PL-61245 Poznan, Poland
[10] Med Univ Lublin, Dept Analyt Chem, Chodzki 4a, PL-20093 Lublin, Poland
[11] Pharm Bjelovar, Petra Preradovica4, Bjelovar 43000, Croatia
[12] Univ Freiburg, Med Ctr, D-79085 Freiburg, Germany
[13] Imed Poland Sp Zoo, PL-02819 Warsaw, Poland
[14] Med Univ Warsaw, Dept Ophthalmol, PL-02091 Warsaw, Poland
关键词
falsified medicines directive; delegated regulation; supply chain; hospital;
D O I
10.3390/ijerph19063276
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) impact the pharmaceutical supply chain. Ahead of the deadline for implementation, in February 2019, every entity of the supply chain had to adapt its operations to the regulatory requirements to be compliant with the directive. This paper analyzes the supply chain of a hospital pharmacy and the impact of the FMD implementation. Furthermore, a cost analysis was performed demonstrating that the FMD increases expenditure in the secondary care environment dispensing operations. Governments should be aware that this regulation will certainly impact public healthcare institutions in the long term.
引用
收藏
页数:11
相关论文
共 45 条
  • [1] THE IMPACT OF THE EUROPEAN DIRECTIVE AGAINST FALSIFIED MEDICINES ON THE PHARMACEUTICAL WHOLESALERS IN BULGARIA
    Valcheva, Krasimira
    JOURNAL OF IMAB, 2021, 27 (01): : 3598 - 3603
  • [2] Pharmacists' views on the impact of the falsified medicines directive on community pharmacies in Ireland
    O'Neill, D.
    Murphy, K. D.
    Dalton, K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 16 - 16
  • [3] The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review
    Melia, Ellen
    English, Aislinn
    Naughton, Bernard D.
    FRONTIERS IN MEDICINE, 2024, 11
  • [4] Pharmacists' views on the impact of the Falsified Medicines Directive on community pharmacies: A cross-sectional survey
    Dalton, Kieran
    Murphy, Kevin D.
    O'Neill, David
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2022, 5
  • [5] When falsified medicines enter the supply chain: Description of an incident in Kenya and lessons learned for rapid response
    Jennifer Cohn
    Tido von Schoen-Angerer
    Elodie Jambert
    Guido Arreghini
    Michelle Childs
    Journal of Public Health Policy, 2013, 34 : 22 - 30
  • [6] When falsified medicines enter the supply chain: Description of an incident in Kenya and lessons learned for rapid response
    Cohn, Jennifer
    von Schoen-Angerer, Tido
    Jambert, Elodie
    Arreghini, Guido
    Childs, Michelle
    JOURNAL OF PUBLIC HEALTH POLICY, 2013, 34 (01) : 22 - 30
  • [7] The impact of the secondary market on the supply chain
    Lee, H
    Whang, S
    MANAGEMENT SCIENCE, 2002, 48 (06) : 719 - 731
  • [8] Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety
    Naughton, Bernard D.
    Smith, James A.
    Brindley, David A.
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (02) : 118 - 120
  • [9] THE IMPACT OF SUPPLY CHAIN MARGINS AND VAT ON THE PRICES OF MEDICINES IN BULGARIA AND GREECE
    Cherneva, D.
    Benisheva, T.
    VALUE IN HEALTH, 2018, 21 : S165 - S166
  • [10] IMPLEMENTATION AND EVALUATION OF A MEDICINES AUTHENTICATION SYSTEM IN A GERMAN SECONDARY CARE ENVIRONMENT
    Merks, Piotr
    Religioni, Urszula
    De Castro, Nuno Pinto
    Drozd, Mariola
    Mack, Christina
    Swieczkowski, Damian
    Zerhau, Mikolaj
    Gawronska, Anna
    Kowalczuk, Anna
    Jaguszewski, Milosz
    Brindley, David
    Hug, Martin
    ACTA POLONIAE PHARMACEUTICA, 2021, 78 (01): : 135 - 146